Publication date: Dec 01, 2024
Rapid telehealth adoption happened at the onset of the coronavirus disease 2019 (COVID-19) pandemic, resulting in a move from in-person predominant to telehealth predominant care delivery. Later, in person visits rebounded with telehealth options remaining. This study aimed to assess differences in healthcare utilization during this changing landscape in terms of health equity determinants. This was an observational cohort study of Johns Hopkins Medicine (JHM) patients. We analyzed utilization of video, telephone, and in-person patient-provider visits by eligible patients between March 16, 2019 and December 31, 2020. Percent changes in average weekly patient-provider visits from pre-pandemic (March 16, 2019-June 30, 2019) to early 2020 pandemic (March 16, 2020-June 30, 2020) and from pre-pandemic (July 1, 2019-December 31, 2019) to late 2020 pandemic (July 1, 2020-December 31, 2020). We used a quantile cut off technique to describe disproportionately smaller or greater drops in visits during the first year of the pandemic among health equity determinant groups and according to visit specialty, when compared to the total population. There was a 39% drop in patient-provider visits from the pre-pandemic to the early 2020 pandemic period, and a 24% drop from pre-pandemic to the late 2020 pandemic period. We discovered 21 groups according to health equity determinates and visit departments with patterns of disproportionately smaller or greater drops in visits during the first year of the pandemic, when compared to the total population: Pattern 1 -smaller drop in visits early and late 2020 (age 45-64, Medicare insurance, high poverty and high unemployment; mental health and medical specialty visits -P
Open Access PDF
Concepts | Keywords |
---|---|
Coronavirus | COVID-19 |
Disproportionately | health equity |
July | telemedicine |
Medicine | |
Weekly |
Semantics
Type | Source | Name |
---|---|---|
disease | MESH | coronavirus disease 2019 |
disease | MESH | unemployment |
drug | DRUGBANK | Methylphenidate |
drug | DRUGBANK | Spinosad |
pathway | REACTOME | Reproduction |
drug | DRUGBANK | Coenzyme M |
drug | DRUGBANK | Fenamole |
drug | DRUGBANK | Ethionamide |
drug | DRUGBANK | L-Valine |